MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR-T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA
Shouse, G.P., Xue, T., Herrera, A., Siddiqi, T., Zain, J., Popplewell, L., Forman, S., Budde, E.Volume:
37
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.190_2631
Date:
June, 2019
File:
PDF, 211 KB
english, 2019